Integrated signatures define mutational processes in prostate cancer
Integrated mutational signatures map DNA damage pathways, offering a new lens on aggressive prostate cancer.
9 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 9 separate news trends connected to Precision Medicine, spanning July 8, 2026 through September 9, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 60 article observations and 58 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
Integrated mutational signatures map DNA damage pathways, offering a new lens on aggressive prostate cancer.
AI is unlocking a new ‘golden age’ in medicine, with personalized treatments to cure cancer and potential to save billions of lives
Recent studies suggest cancer cells may behave like quantum systems, occupying limited, shared states.
A $100 heart scan could help some adults decide whether to start taking statins.
McKesson is spending $2.25 billion to buy Precision Medicine Group, a major move in clinical research.
Lung cancer testing is evolving rapidly, with new advancements and barriers shaping patient care.
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
A new breathalyser technology can detect fat metabolism from a single exhalation, sparking interest in personal health monitoring.
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.